Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG)-Reference-Cited by-同舟云学术

Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG)

Published:1987-09 Issue:5 Volume:8 Page:855-861
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Rajakumar G.,Naas F.,Johnson R.L.,Chiu S.,Yu K.L.,Mishra R.K.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference32 articles.

1. Newer therapeutic approaches in Parkinson's Disease;Barbeau,1978

2. Inhibition of neuroleptic-induced dopamine receptor supersensitivity by cyclo (leu-gly);Bhargava;Pharmacol Biochem Behav,1980

3. The effect of hypothalamic peptide factor, MIF and its cyclic analog on tolerance to haloperidol in the rat;Bhargava;Life Sci,1981

4. Effect of pro-leu-gly-NH2 and analogs on [3H]spiroperidol and [3H]apomorphine binding to rat striatal and hypothalamic dopamine receptors;Bhargava;Pharmacologist,1982

5. Cyclo(leu-gly): a possible treatment for tardive dyskinesia?;Bhargava;Mod Probl Pharmacopsychiatry,1983

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D₂ Receptors;ACS Medicinal Chemistry Letters;2023-11-14

2. Transformation of Pro-Leu-Gly-NH2 Peptidomimetic Positive Allosteric Modulators of the Dopamine D2 Receptor into Negative Modulators;ACS Chemical Neuroscience;2012-02-01

3. Tripeptide Motifs in Biology: Targets for Peptidomimetic Design;Journal of Medicinal Chemistry;2011-01-28

4. Allosteric Modulation of the Dopamine D2 Receptor by Pro-Leu-Gly-NH2 Peptidomimetics Constrained in Either a Polyproline II Helix or a Type II β-Turn Conformation;Journal of Medicinal Chemistry;2009-03-09

5. Differential striatal levels of TNF-α, NFκB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: Role in orofacial dyskinesia;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2008-08